Literature DB >> 9347902

Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.

Q Qiu1, J W Overstreet, H Todd, S T Nakajima, D R Stewart, B L Lasley.   

Abstract

Total concentrations of follicle stimulating hormone (FSH) were evaluated in daily urine samples from conceptive and nonconceptive menstrual cycles by measurement of the FSH beta subunit following treatment of the samples to dissociate the FSH heterodimer. Samples were self-collected by normal subjects during cycles in which daily blood samples also were obtained. Daily blood and urine specimens were collected prospectively from 10 subject in conceptive cycles, which led to normal pregnancies, and from 10 subjects with bilateral tubal ligations to provide control samples form nonconceptive cycles. Mean serum and urinary FSH concentration profiles wer parallel in both groups following ovulation and during he first 9 days of the luteal phase. Mean values for both serum and urinary FSH rose significantly above the postovulatory baseline by 10-12 days following the midcycle luteinizing hormone (LH) peak in nonconceptive cycles, but did not rise at any time following ovulation during conceptive cycles. Following regression analysis of the changing FSH concentration between days 9-14 post-LH surge in conceptive cycles, a slope of </= 0.02 ng FHS/mg creatinine/day was selected as a cutoff point to identify conceptive cycles. There was a high concordance between the day of LH peak in serum and the day of FSH peak in urine. Therefore, in applying the algorithm, the day of FSH peak in urine was used to determine the days for which the FSH slope would be calculated, i.e., days 9-14 post-FSH peak in urine. The sensitivity and specificity of the change in urinary FSH concentrations to detect pregnancy in a different set of 55 cycles were found to 88.9% and 89.3%, respectively. All six cases of early fetal loss in the sample set were correctly identified. These results suggest that urinary FSH can be used as an additional biomarker for the verification of early pregnancy in prospective epidemiological studies in which early fetal loss is a suspected outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347902      PMCID: PMC1470195          DOI: 10.1289/ehp.97105862

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay.

Authors:  C J Munro; G H Stabenfeldt; J R Cragun; L A Addiego; J W Overstreet; B L Lasley
Journal:  Clin Chem       Date:  1991-06       Impact factor: 8.327

2.  Mapping of an assembled epitope of human follicle-stimulating hormone-beta utilizing monoclonal antibodies, synthetic peptides, and hormone-receptor inhibition.

Authors:  D D Vakharia; J A Dias; A N Thakur; T T Andersen; A O'Shea
Journal:  Endocrinology       Date:  1990-08       Impact factor: 4.736

3.  Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.

Authors:  J F O'Connor; J P Schlatterer; S Birken; A Krichevsky; E G Armstrong; D McMahon; R E Canfield
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

4.  Enzyme immunoassay method for total alpha gonadotropin in human urine samples.

Authors:  K M Clough; F X Cole; S S Seaver; A Vesprini; A Y Kuo; B L Lasley
Journal:  Fertil Steril       Date:  1992-06       Impact factor: 7.329

5.  Prospective monitoring of early fetal loss and clinical spontaneous abortion among female semiconductor workers.

Authors:  B Eskenazi; E B Gold; B L Lasley; S J Samuels; S K Hammond; S Wight; M O'Neill Rasor; C J Hines; M B Schenker
Journal:  Am J Ind Med       Date:  1995-12       Impact factor: 2.214

6.  The relationship between hCG and relaxin secretion in normal pregnancies vs peri-implantation spontaneous abortions.

Authors:  D R Stewart; J W Overstreet; A C Celniker; D L Hess; J R Cragun; S P Boyers; B L Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  1993-04       Impact factor: 3.478

7.  Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle.

Authors:  W D Odell; J Griffin
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

8.  Pulsatile secretion of human chorionic gonadotropin in normal adults.

Authors:  W D Odell; J Griffin
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

9.  Incidence of early loss of pregnancy.

Authors:  A J Wilcox; C R Weinberg; J F O'Connor; D D Baird; J P Schlatterer; R E Canfield; E G Armstrong; B C Nisula
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

10.  Enhanced ovarian steroid secretion before implantation in early human pregnancy.

Authors:  D R Stewart; J W Overstreet; S T Nakajima; B L Lasley
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

View more
  8 in total

1.  Comparative study of urinary reproductive hormones in great apes.

Authors:  Keiko Shimizu; Toshifumi Udono; Chihiro Tanaka; Etsuo Narushima; Masato Yoshihara; Masato Takeda; Atsu Tanahashi; Linda van Elsackar; Motoharu Hayashi; Osamu Takenaka
Journal:  Primates       Date:  2003-02-14       Impact factor: 2.163

2.  Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

3.  Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Lori Cray; Ellen Sullivan Mitchell; Jerald R Herting
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

4.  Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Kathleen Smith-Dijulio
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

5.  Cigarette smoking and effects on hormone function in premenopausal women.

Authors:  Gayle C Windham; Patrick Mitchell; Meredith Anderson; Bill L Lasley
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

6.  Biomarkers for assessing human female reproductive health, an interdisciplinary approach.

Authors:  B L Lasley; J W Overstreet
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

7.  Depressed mood during the menopausal transition: is it reproductive aging or is it life?

Authors:  Ellen Sullivan Mitchell; Nancy Fugate Woods
Journal:  Womens Midlife Health       Date:  2017-12-11

8.  Abdominal pain during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nini G L Callan; Ellen S Mitchell; Margaret M Heitkemper; Nancy F Woods
Journal:  Womens Midlife Health       Date:  2019-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.